Literature DB >> 16501934

CB1 and TRPV1 receptors mediate protective effects on colonic electrophysiological properties in mice.

A Sibaev1, F Massa, B Yüce, G Marsicano, H A Lehr, B Lutz, B Göke, H D Allescher, M Storr.   

Abstract

CB1 and TRPV1 receptors modulate enteric neurotransmission and colonic inflammation. This study investigates early electrophysiological changes in distal colon of wild-type and receptor deficient mice after an inflammatory insult set by dinitrobenzene sulfonic acid (DNBS). Colitis was induced by DNBS in CB1(-/-) mice, TRPV1(-/-) mice, and their respective wild-type littermates. Electrophysiological properties consisting of membrane potentials and electrically induced inhibitory junction potentials (IJP) of circular smooth muscle cells were evaluated at different time points. Additionally a histological colitis severity score was evaluated in CB1(+/+) and CB1(-/-) mice 24 h after DNBS. Inflammation caused spontaneous atropine insensitive rhythmic action potentials in CB1(-/-) and TRPV1(-/-) mice but not in wild-type animals. This indicates that membrane stability is disturbed, which in turn indicates a lack of protective mechanisms. Focal electrical neuronal stimulation of the myenteric plexus induced IJP in the smooth muscle cells. Twenty-four hours after initiation of inflammation, the duration of the IJP is prolonged in all animals, indicating disturbances within neuromuscular interaction. In CB1(-/-) mice, it is interesting that the duration of IJP was significantly extended, as compared to CB1(+/+) mice pointing toward missing protective mechanisms in the CB1(-/-) mice. Inflammatory insults in the mouse colon induce reproducible changes in the electrophysiological properties and such changes correlate with duration of colitis. In mutants, these electrophysiological changes display different patterns, suggesting the lack of protective properties for neuromuscular interactions and membrane stability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501934     DOI: 10.1007/s00109-006-0040-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  32 in total

Review 1.  The gastrointestinal pharmacology of cannabinoids.

Authors:  A A Izzo; N Mascolo; F Capasso
Journal:  Curr Opin Pharmacol       Date:  2001-12       Impact factor: 5.547

2.  Acute experimental distal colitis alters colonic transit in rats.

Authors:  B S Myers; D T Dempsey; S Yasar; J S Martin; H P Parkman; J P Ryan
Journal:  J Surg Res       Date:  1997-04       Impact factor: 2.192

3.  Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors.

Authors:  A A Izzo; N Mascolo; F Borrelli; F Capasso
Journal:  Br J Pharmacol       Date:  1998-08       Impact factor: 8.739

4.  Effect of cannabinoids on neural transmission in rat gastric fundus.

Authors:  M Storr; E Gaffal; D Saur; V Schusdziarra; H D Allescher
Journal:  Can J Physiol Pharmacol       Date:  2002-01       Impact factor: 2.273

5.  Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil.

Authors:  A A Izzo; L Pinto; F Borrelli; R Capasso; N Mascolo; F Capasso
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

6.  IL-1 beta -converting enzyme (caspase-1) in intestinal inflammation.

Authors:  B Siegmund; H A Lehr; G Fantuzzi; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

7.  The endogenous cannabinoid system protects against colonic inflammation.

Authors:  Federico Massa; Giovanni Marsicano; Heike Hermann; Astrid Cannich; Krisztina Monory; Benjamin F Cravatt; Gian-Luca Ferri; Andrei Sibaev; Martin Storr; Beat Lutz
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

8.  Spontaneous contractions and some electrophysiologic properties of circular muscle from normal sigmoid colon and ulcerative colitis.

Authors:  T R Koch; J A Carney; V L Go; J H Szurszewski
Journal:  Gastroenterology       Date:  1988-07       Impact factor: 22.682

9.  In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum.

Authors:  T Croci; L Manara; G Aureggi; F Guagnini; M Rinaldi-Carmona; J P Maffrand; G Le Fur; S Mukenge; G Ferla
Journal:  Br J Pharmacol       Date:  1998-12       Impact factor: 8.739

10.  Structural differences in the enteric neural network in murine colon: impact on electrophysiology.

Authors:  Andrei Sibaev; Hartmut Franck; Jean-Marie Vanderwinden; Hans-Dieter Allescher; Martin Storr
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-07-24       Impact factor: 4.052

View more
  11 in total

1.  Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.

Authors:  H Yang; Z Wang; J E Capó-Aponte; F Zhang; Z Pan; P S Reinach
Journal:  Exp Eye Res       Date:  2010-07-07       Impact factor: 3.467

Review 2.  Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system.

Authors:  Peter Holzer
Journal:  Pharmacol Ther       Date:  2011-03-21       Impact factor: 12.310

3.  The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.

Authors:  Martin Storr; Dominik Emmerdinger; Julia Diegelmann; Simone Pfennig; Thomas Ochsenkühn; Burkhard Göke; Peter Lohse; Stephan Brand
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

4.  Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis.

Authors:  Martin A Storr; Catherine M Keenan; Hong Zhang; Kamala D Patel; Alexandros Makriyannis; Keith A Sharkey
Journal:  Inflamm Bowel Dis       Date:  2009-11       Impact factor: 5.325

5.  Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors.

Authors:  Martin A Storr; Catherine M Keenan; Dominik Emmerdinger; Hong Zhang; Birol Yüce; Andrei Sibaev; Federico Massa; Nancy E Buckley; Beat Lutz; Burkhard Göke; Stephan Brand; Kamala D Patel; Keith A Sharkey
Journal:  J Mol Med (Berl)       Date:  2008-05-21       Impact factor: 4.599

Review 6.  Plasticity of enteric nerve functions in the inflamed and postinflamed gut.

Authors:  G M Mawe; D S Strong; K A Sharkey
Journal:  Neurogastroenterol Motil       Date:  2009-03-11       Impact factor: 3.598

7.  Topical and systemic cannabidiol improves trinitrobenzene sulfonic acid colitis in mice.

Authors:  Rudolf Schicho; Martin Storr
Journal:  Pharmacology       Date:  2012-03-12       Impact factor: 2.547

8.  Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice.

Authors:  Edward S Kimball; Nathaniel H Wallace; Craig R Schneider; Michael R D'Andrea; Pamela J Hornby
Journal:  Front Pharmacol       Date:  2010-11-19       Impact factor: 5.810

9.  Role of the transient receptor potential vanilloid 1 in inflammation and sepsis.

Authors:  Isabel Devesa; Rosa Planells-Cases; Gregorio Fernández-Ballester; José Manuel González-Ros; Antonio Ferrer-Montiel; Asia Fernández-Carvajal
Journal:  J Inflamm Res       Date:  2011-05-24

10.  New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view.

Authors:  Asia Fernández-Carvajal; Gregorio Fernández-Ballester; Isabel Devesa; José Manuel González-Ros; Antonio Ferrer-Montiel
Journal:  Pharmaceuticals (Basel)       Date:  2011-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.